Abstract
Pharmaceutical forms containing glycosamines and chondroitins in their composition stimulate the synthesis of articular proteoglycans. In addition, glucosamine exhibits anti-inflammatory properties, slows down the degradation of articular cartilage, mainly due to its metabolic activity, the ability to inhibit the activity of interleukin (IL)-1, lysosomal enzymes, collagenase and phospholipase A2. The effect of treatment with glucosamine sulfate is noticeable after 2 weeks from the start of treatment. The question remains how and in what sequence to use chondroprotective drugs to normalize the work of joint structures.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
